What an MPA diagnosis means
MPA is diagnosed from the whole picture: symptoms, examination, blood and urine tests, ANCA results and often a biopsy.
Every medical claim on this page links to its source. Last updated 15 November 2026. Educational information, not medical advice.
In plain language
- MPA is part of ANCA-associated vasculitis (AAV). Most people with MPA have MPO-ANCA; PR3-ANCA and negative results also occur.1,2
- Early symptoms can be general: tiredness, fever, weight loss and joint aches. More specific signs point to the kidneys, lungs, nerves or skin.1,3
- Kidney involvement can be silent, which is why urine and blood tests matter even when you feel well.1
- Infections, other autoimmune diseases and some medicines can look like vasculitis, so your team checks for them.1,3
What the team looks for
- Symptoms and organ examination to identify active disease.
- Kidney tests: creatinine, eGFR, urinalysis with microscopy, and a urine protein measurement. Tests explained
- MPO- and PR3-ANCA results, interpreted in context. Anti-GBM testing may matter with rapidly worsening kidney function or lung bleeding.
- A kidney biopsy when feasible. In a rapidly worsening patient with a convincing picture and a positive MPO or PR3 test, treatment may need to start before biopsy results are back.
- Lung imaging, oxygen levels, nerve studies or skin biopsy when symptoms point there.1,3,4
Next steps
Biopsy and other tests · Questions for your first appointment
For researchers and clinicians
KDIGO 2024 and EULAR 2022 support ANCA testing by antigen-specific immunoassay; biopsy shows pauci-immune glomerulonephritis and the extent of chronic damage. Drug-induced AAV (e.g., hydralazine, propylthiouracil) should be considered.1,5
Sources
- KDIGO: KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis [doc ref 1]
- Vasculitis Foundation: Microscopic polyangiitis (MPA) [doc ref 7]
- Rheumatology (2025): 2025 British Society for Rheumatology recommendations for ANCA-associated vasculitis [doc ref 40]
- Pathologica (2024): Pulmonary pathology in vasculitis [doc ref 51]
- Annals of the Rheumatic Diseases (2024): EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update [doc ref 40]
Links checked 15 November 2026. Full list: all sources.